Poll: Do You Agree with the FDA's Decision to Pull Avastin?

Article

This week the FDA pulled its accelerated approval of Avastin for women with HER2-negative metastatic breast cancer who have not undergone chemotherapy.

Everyone wants the best treatment available when it comes to cancer, breast cancer is no different. This week the FDA pulled its accelerated approval of Avastin for women with HER2-negative metastatic breast cancer who have not undergone chemotherapy. Avastin is still available for other types of cancer but because it is no longer approved for breast cancer insurance companies will not cover the approximately $8000.00 per month it costs. This puts breast cancer treatment out of reach for many women who say this was working for them.

Recent Videos
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Shayna Mancuso, DO, highlights the real impact of menopause | Image Credit: linkedin.com.
Jihong Liu, ScD, explains how to improve perinatal outcomes in COVID patients | Image Credit: sc.edu.
1 expert is featured in this series.
Jihong Liu, ScD, highlights adverse perinatal outcomes linked to the COVID pandemic | Image Credit: sc.edu.
Experts highlight infant health benefits from minor diet changes in pregnancy | Image Credit: ohsu.edu.
Connie Stark, RNC, PNC, provides fertility preservation insights for endometriosis patients | Image Credit: linkedin.com.
How the impact of maternal diet on infant health is strengthened in late pregnancy | Image Credit: ohsu.edu.
Related Content
Contemporary OB/GYN week in review: Menstrual symptoms, cognitive decline, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: Menstrual symptoms, cognitive decline, and more

Celeste Krewson, Assistant Editor
April 18th 2025
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Read More

Pap Talk S4E15: MIRA surgical system for hysterectomy with Jean Dubuisson, MD, PhD

Pap Talk S4E15: MIRA surgical system for hysterectomy with Jean Dubuisson, MD, PhD

Celeste Krewson, Assistant Editor
December 31st 2024
Podcast

In this episode of Pap Talk, Jean Dubuisson, MD, PhD, discusses the first successful hysterectomy performed using the MIRA surgical system.

Listen

Screening mammograms linked to earlier breast cancer detection | Image Credit: © Peakstock - © Peakstock - stock.adobe.com.

Screening mammograms linked to earlier breast cancer detection

Celeste Krewson, Assistant Editor
April 18th 2025
Article

A new study found that routine mammography significantly reduces late-stage diagnoses and mortality in women aged 70 years and older.

Read More

Site Logo

How Individually Identifying More HPV Types Enables Better Patient Management and More Precise Care

September 29th 2023
Podcast

Listen

Stephanie Pearson, MD, FACOG

From patients to patience: An ob-gyn’s journey from provider to patient

Stephanie Pearson, MD, FACOG
April 17th 2025
Article

Stephanie Pearson, MD, FACOG, shares her journey transitioning from a provider to a patient following a work-related accident.

Read More

Subclinical hypothyroidism may worsen metabolic health in PCOS patients | Image Credit: © mi_viri - © mi_viri - stock.adobe.com.

Subclinical hypothyroidism may worsen metabolic health in PCOS patients

Celeste Krewson, Assistant Editor
April 17th 2025
Article

A new study reveals that polycystic ovary syndrome patients with subclinical hypothyroidism face greater risks of hormonal and metabolic imbalances.

Read More

© 2025 MJH Life Sciences

All rights reserved.